ArticleAssessment2020
Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.
Article in Assessment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- The Effect of Translation and Cultural Adaptations on Diagnostic Accuracy and Test Performance in Dementia Cognitive Screening Tools: A Systematic Review.Journal of Alzheimer's disease reports · 2024Pooled it
- Clinical Outcome Measure Crosswalks in Alzheimer's Disease: A Systematic Review.Journal of Alzheimer's disease : JAD · 2021Pooled it
- Evaluation of diagnostic concordance between algorithms for Parkinson's disease dementia.Journal of Parkinson's disease · 2026Article
- Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth.Schizophrenia bulletin · 2025Article
- Automated analysis of spoken language differentiates multiple system atrophy from Parkinson's disease.Journal of neurology · 2025Article
- Investigating the factor structure of the Montreal Cognitive Assessment: a qualitative review.Frontiers in psychology · 2025Review
- Study protocol for identification of patients with risk of cognitive impairment in advanced pharmaceutical care in a community pharmacy.Frontiers in public health · 2025Article
- Critical evaluation of COSMIN scores in scales for mild cognitive impairment and Alzheimer's disease: A comprehensive review.Journal of Alzheimer's disease reports · 2024Review
- Development of a Swedish short version of the Montreal Cognitive Assessment for cognitive screening in patients with stroke.Journal of rehabilitation medicine · 2023Article
- Construction of a computerized adaptive test (CAT-CCNB) for efficient neurocognitive and clinical psychopathology assessment.Journal of neuroscience methods · 2023Article
- A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease.Frontiers in aging neuroscience · 2022Article
- When CAT is not an option: complementary methods of test abbreviation for neurocognitive batteries.Cognitive neuropsychiatry · 2021Article
- Accuracy of the Short-Form Montreal Cognitive Assessment Chinese Versions.Frontiers in aging neuroscience · 2021Article
- A 4-Item Case-Finding Tool to Detect Dementia in Older Persons.Journal of the American Medical Directors Association · 2019Article
- The Optimal Short Version of Montreal Cognitive Assessment in Diagnosing Mild Cognitive Impairment and Dementia.Journal of the American Medical Directors Association · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 2 countries.
Funding
Abstract
The Montreal Cognitive Assessment (MoCA) is one of the most common screening instruments for mild cognitive impairment. However, the standard MoCA is approximately two times longer to administer than the Mini-Mental State Examination. A total of 699 Czech and 175 American participants received the standard MoCA Czech and English versions and in the clinical part, a sample of 102 nondemented patients with Parkinson's disease (PD). We created a validated Czech short version (s-MoCA-CZ) from the original using item response theory. As expected, s-MoCA-CZ scores were highly correlated with the standard version (Pearson
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.